Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

35.57
Delayed Data
As of 3:59pm ET
 -0.63 / -1.74%
Today’s Change
19.59
Today|||52-Week Range
65.34
-42.56%
Year-to-Date
Ionis/Biogen Complete Nusinersen NDA Submission in U.S.
Sep 27 / Zacks.com - Paid Partner Content
3 Ways Ionis Pharmaceuticals, Inc. Is Beating the Competition
Sep 19 / MotleyFool.com - Paid Partner Content
3 Stocks That Could Make You Rich
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close36.20
Today’s open36.42
Day’s range35.48 - 36.61
Volume1,246,059
Average volume (3 months)2,768,788
Market cap$4.4B
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-44.49%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book21.70

Competitors

 Today’s
change
Today’s
% change
PTHNPatheon NV+0.03+0.10%
AGNPRAAllergan plc-20.16-2.39%
GRFSGrifols SA-0.22-1.37%
ICPTIntercept Pharmaceut...-7.45-4.44%
Data as of 4:00pm ET, 09/29/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts

Search for Jobs